Value of endorectal MRI and MRS in patients with elevated prostate-specific antigen levels and previous negative biopsies to localize peripheral zone tumours-Reference-Cited by-同舟云学术

Value of endorectal MRI and MRS in patients with elevated prostate-specific antigen levels and previous negative biopsies to localize peripheral zone tumours

Published:2008-08 Issue:8 Volume:63 Page:871-879
ISSN:0009-9260
Container-title:Clinical Radiology
language:en
Short-container-title:Clinical Radiology

Author:

Cirillo S.,Petracchini M.,Della Monica P.,Gallo T.,Tartaglia V.,Vestita E.,Ferrando U.,Regge D.

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging,General Medicine

Reference29 articles.

1. Epidemiology of prostate cancer;Crawford;Urology,2003

2. Repeat prostate biopsy: who, how and when? A review;Djavan;Eur Urol,2002

3. European randomized study of screening for prostate cancer: achievements and presentation;Roobol;BJU Int,2003

4. Prospective evaluation of prostate cancer detected on biopsies 1, 2, 3 and 4: when should we stop?;Djavan;J Urol,2001

5. Prostate cancer detection and tumor characteristics in men with multiple biopsy sessions;Lujan;Prostate Cancer Prostatic Dis,2004

Cited by 67 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multiparametric Magnetic Resonance Imaging in Evaluation of Clinically Significant Prostate Cancer;Indian Journal of Radiology and Imaging;2021-05-23

2. Nuclear magnetic resonance spectroscopy of human body fluids and in vivo magnetic resonance spectroscopy: Potential role in the diagnosis and management of prostate cancer;Urologic Oncology: Seminars and Original Investigations;2020-04

3. MRI to guide biopsies or avoid biopsies?;Current Opinion in Urology;2018-11

4. A systematic review on multiparametric MR imaging in prostate cancer detection;Infectious Agents and Cancer;2017-10-30

5. What Is the Negative Predictive Value of Multiparametric Magnetic Resonance Imaging in Excluding Prostate Cancer at Biopsy? A Systematic Review and Meta-analysis from the European Association of Urology Prostate Cancer Guidelines Panel;European Urology;2017-08